Coral Gables, Fla.-based Baptist Health South Florida will launch an early-phase cancer clinical trial site in partnership with San Antonio-based START Center for Cancer Research. The site will operate in collaboration with Baptist Health’s Herbert Wertheim Cancer Institute, which was…
Author: Elizabeth Gregerson
A new law ensures Iowa City-based University of Iowa Stead Family Children’s Hospital will receive up to $3 million per year for pediatric cancer research through a tax on vape and other alternative nicotine products. Iowa Gov. Kim Reynolds, signed…
In a lawsuit filed May 25, Sunil Hingorani, MD, PhD, director of Omaha-based University of Nebraska Medical Center’s Pancreatic Cancer Center of Excellence, accused UNMC and Nebraska Medicine of racial discrimination and retaliation. Here are five things to know regarding…
Charlotte, N.C.-based Advocate Health has launched a partnership with AI platform Lind to improve patient identification and matching for cancer clinical trials. The health system will embed Lind’s platform into its EHR to automatically screen patients for clinical trial eligibility,…
The Medical College of Georgia at Augusta (Ga.) University has appointed David Munn, MD, director of the Georgia Cancer Center. Dr. Munn has served as the cancer center’s interim director since March, according to a May 26 news release from…
Advertisement
The American Cancer Society has updated its colorectal cancer screening recommendations to include considerations for blood-based and at-home screening. The updated guidelines were published May 27 in CA: A Cancer Journal for Clinicians. Here are five notes from the update:…
Cleveland Clinic has launched a partnership with bioanalytics company Aspira Women’s Health to advance diagnostics through AI. The organizations aim to accelerate the development and future commercialization of multiomic diagnostics across women’s health, according to a May 26 news release…
The healthcare industry is primed to push diagnostic AI beyond pilot-stage experimentation, with new studies showing gains in detection of cancer, heart disease and even substance use disorders. As some diagnostic models approach near-perfect accuracy, broader clinical reasoning may still…
Boston-based Dana-Farber Cancer Institute has appointed Andrew Lane, MD, PhD, as chief of the division of hematologic neoplasia. The cancer institute announced Dr. Lane’s appointment in a May 24 LinkedIn post. Dr. Lane joined Dana-Farber in 2008 and has served…
On May 13, HHS Secretary Robert F. Kennedy Jr. met with leaders from Duarte, Calif.-based City of Hope as part of the cancer center’s “The Next Frontier of Cancer Prevention and Care: The Microbiome” event. The event brought together researchers…